LanguaTalk

Foundation Fighting Blindness

The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.

VeonGen Reports Promising Clinical Progress for Stargardt Disease Gene Therapy

2 mins; March 26, 2026

Sumitomo Pharma Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment

2 mins; March 24, 2026

Octant Bio Begins Clinical Testing Oral Treatment for Rhodopsin-Related Retinitis Pigmentosa

2 mins; March 11, 2026

Opus Genetics Reports Promising Early Results from BEST1 Gene Therapy Trial

2 mins; March 02, 2026

Eye on the Cure Podcast | Episode 100: BEST OF

35 mins; February 27, 2026

SparingVision Completes Dosing in Gene-Agnostic Therapy Trial for Retinitis Pigmentosa (RP)

2 mins; February 11, 2026

Blind & Beyond Radio Spotlight: Jason Menzo on Vision Research and Advocacy

15 mins; February 08, 2026

Eye on the Cure Podcast | Episode 99: Dr. Prem Subramanian

28 mins; February 06, 2026

Opus Genetics Receives Funding for Gene Therapy Clinical Trial for MERTK-Related RP

2 mins; January 28, 2026

AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B

2 mins; January 16, 2026

SpliceBio Begins Dose-Expansion Phase of Clinical Trial for Stargardt Disease Protein Splicing Therapy

3 mins; January 13, 2026

Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg

47 mins; January 09, 2026

Eye on the Cure Podcast | Episode 97: Lindsey Rambo

39 mins; December 19, 2025

Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy

2 mins; December 18, 2025

Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara

43 mins; December 05, 2025

Belite Bio to Seek FDA Approval for its Stargardt Disease Drug

3 mins; December 02, 2025

Opus Genetics Launches Gene Therapy Clinical Trial for Best Disease

2 mins; November 14, 2025

Eye on the Cure Podcast | Episode 95: Greta Streimikyte

20 mins; November 14, 2025

Eye on the Cure Podcast | Episode 94: Dr. Victoria Claire

53 mins; October 31, 2025

SparingVision Launches Clinical Trial for Therapy to Re-Activate Dormant Cones in Advanced RP

4 mins; October 28, 2025

Eye on the Cure Podcast | Episode 93: Sam Seavey

41 mins; October 17, 2025

Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial

3 mins; October 02, 2025

Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy

4 mins; September 30, 2025

Eye on the Cure Podcast | Episode 92: Lance Baldo, MD

30 mins; September 26, 2025

Agnes Gund – Renowned Philanthropist, Social Justice Champion, and Art Patron – Passes Away

2 mins; September 22, 2025

Nacuity’s Antioxidative Therapy NACA Performs Encouragingly in Phase 1/2 Clinical Trial

3 mins; September 12, 2025

Eye on the Cure Podcast | Episode 91: Dr. George Magrath

22 mins; September 05, 2025

Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy

2 mins; August 22, 2025

jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy

3 mins; August 20, 2025

Eye on the Cure Podcast | Episode 90: Dr. Christina Ohnsman

27 mins; August 08, 2025

Wet AMD Treatment Susvimo Preserves Vision for Five Years in Phase 3 Clinical Trial

3 mins; August 06, 2025

Eye on the Cure Podcast | Episode 89: Dr. Christine Curcio

37 mins; July 25, 2025

Ocugen Launches Phase 2/3 Clinical Trial for Stargardt Disease Gene-Modifier Therapy

1 min; July 21, 2025

Nanoscope Begins Rolling BLA Submission to FDA for Seeking Approval for its Optogenetic Therapy

2 mins; July 14, 2025

Eye on the Cure Podcast | Episode 88: Richard Small

25 mins; July 11, 2025

Atsena Gets FDA Nod to Expand XLRS Gene Therapy Clinical Trial to Include Pivotal Phase 3 Cohort

4 mins; July 09, 2025

Eye on the Cure Podcast | Episode 87: Dr. Philip Beales

18 mins; June 13, 2025

Eye on the Cure Podcast | Episode 86: Lenore von Krusenstiern, MD, PhD

31 mins; May 23, 2025

J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial

2 mins; May 15, 2025

ARVO 2025 Highlight: PYC Reports Encouraging Phase 1/2 Clinical Trial Results for its RNA Therapy Targeting RP (PRPF31 Mutations)

4 mins; May 13, 2025

ARVO 2025 Highlight: Atsena’s XLRS Gene Therapy Provides Vision and Structural Improvements in Phase 1/2 Clinical Trial

4 mins; May 12, 2025

ARVO 2025 Highlight: Beacon Reports Encouraging Results for Second Eyes Dosed in Clinical Trial for XLRP Gene Therapy

3 mins; May 09, 2025

Eye on the Cure Podcast | Episode 85: Cindy Elden

28 mins; May 09, 2025

Eye on the Cure Podcast | Episode 84: Contact Congress

35 mins; April 01, 2025

Eye on the Cure Podcast | Episode 83: Michel Michaelides

33 mins; March 19, 2025

Luxa Reports Vision Improvements in Clinical Trial of its RPE Stem Cell Therapy for Dry AMD

4 mins; March 10, 2025

Neurotech’s Encapsulated Cell Technology Receives FDA Approval for Treatment of MacTel

2 mins; March 06, 2025

Eye on the Cure Podcast | Episode 82: Dr. Aaron Nagiel

32 mins; March 04, 2025

Adverum Advancing Wet AMD Gene Therapy into Phase 3 Clinical Trials

3 mins; February 27, 2025

LCA4 Gene Therapy Restores Meaningful Vision for Blind Children

3 mins; February 23, 2025

Eye on the Cure Podcast | Episode 81: Ricky Enger

49 mins; February 19, 2025

RD Fund Invests in Perceive Pharma for Development of Neuroprotective Therapies

2 mins; February 17, 2025

Harriet Finkelstein, Foundation Angel, Passes Away

3 mins; February 04, 2025

Eye on the Cure Podcast | Episode 80: Aniz Girach, MD

26 mins; January 24, 2025

Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy

4 mins; January 09, 2025

Eye on the Cure Podcast | Episode 79: Damon Lembi

35 mins; January 05, 2025

ViGeneron Receives FDA Authorization to Launch Clinical Trial for mRNA Trans-splicing Gene Therapy for Stargardt Disease

3 mins; December 19, 2024

Eye on the Cure Podcast | Episode 78: Dr. Sheldon Rowan

40 mins; December 16, 2024

SpliceBio Receives FDA Clearance to Launch Clinical Trial for Stargardt Disease Protein Splicing Therapy

2 mins; December 15, 2024

Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy

3 mins; December 11, 2024

Eye on the Cure Podcast | Episode 77: Dr. Bob Bell

32 mins; December 03, 2024

Atsena’s LCA1 Gene Therapy Licensed by Nippon Shinyaku for Markets in US and Japan

3 mins; November 12, 2024

Eye on the Cure Podcast | Episode 76: The Lemay-Pelletier Family

28 mins; November 11, 2024

BlueRock’s Photoreceptor Cell Therapy to Move into Clinical Trial

2 mins; October 29, 2024

Kiora Receives Authorization for Phase 2 Clinical Trial of its Photoswitch for Advanced RP

3 mins; October 28, 2024

Eye on the Cure Podcast | Episode 75: Sharon King

37 mins; October 25, 2024

Opus Genetics, Ocuphire Merger to Boost Advancement of Several IRD Gene Therapies

2 mins; October 23, 2024

#ShareYourVision | White Cane Day

36 secs; October 15, 2024

Safety Clinical Trial Launched for Usher Syndrome 3 Drug

2 mins; October 11, 2024

#ShareYourVision this Blindness Awareness Month | Jessie’s Story

59 secs; October 11, 2024

Eye on the Cure Podcast | Episode 74: Dr. Kia Washington

34 mins; October 11, 2024

#ShareYourVision | What do you want others to know about your unique vision?

35 secs; October 10, 2024

Vision: A Memoir of Blindness and Justice — A New York Times Editor’s Pick

2 mins; September 26, 2024

4DMT Planning Phase 3 Clinical Trial for Wet AMD Gene Therapy

3 mins; September 23, 2024

Eye on the Cure Podcast | Episode 73: Dr. Zuhal Butuner

19 mins; September 20, 2024

AAVantgarde Bio’s Dual-Vector USH1B Gene Therapy Moves into Phase 1/2 Clinical Trial

3 mins; September 18, 2024

Nanoscope Planning Phase 3 Trial of its Optogenetic Therapy for People with Stargardt Disease

2 mins; September 17, 2024

Eye on the Cure Podcast | Episode 72: Hannah Scanga

41 mins; August 23, 2024

Eye on the Cure Podcast | Episode 71: Dr. Leonide Saad

34 mins; August 09, 2024

Beacon Story | Para triathlete Deb Chucoski

11 mins; August 06, 2024

AREDS Formula Reduces Risk of Visual Acuity Loss for People with Geographic Atrophy

2 mins; July 30, 2024

Eye on the Cure Podcast | Episode 70: Karen Petrou

22 mins; July 26, 2024

VISIONS 2024 | Karen Petrou "Vision for the Future"

20 mins; July 19, 2024

VISIONS 2024 | Tribute, Awards and Closing

57 mins; July 19, 2024

VISIONS 2024 | Eye Health and Nutrition

66 hours 46 mins; July 19, 2024

VISIONS 2024 | Gene Agnostic Therapeutic Approaches

64 hours 58 mins; July 19, 2024

VISIONS 2024 | Clinical Trials: What Should You Know?

67 hours 6 mins; July 19, 2024

VISIONS 2024 | Emerging Technologies

68 hours 14 mins; July 19, 2024

VISIONS 2024 | Genetic Therapies: Gene Therapy and Genome Editing

55 mins; July 19, 2024

VISIONS 2024 | Stem Cells and Regenerative Medicine (session two)

50 mins; July 19, 2024

VISIONS 2024 | Stem Cells and Regenerative Medicine (session one)

51 mins; July 19, 2024

VISIONS 2024 | Optogenetics for Sight Restoration (session one)

57 mins; July 19, 2024

VISIONS 2024 | Optogenetics for Sight Restoration (session two)

64 hours 34 mins; July 19, 2024

VISIONS 2024 | Inherited Retinal Disease Genetics: Testing and Registries

63 hours 40 mins; July 19, 2024

VISIONS 2024 | Clinical Trial Readiness

65 hours 17 mins; July 19, 2024

VISIONS 2024 | Navigating Air Travel—A Southwest Airlines Perspective

60 hours 57 mins; July 19, 2024

VISIONS 2024 | My Advocacy. My Choice.

64 hours 2 mins; July 19, 2024

VISIONS 2024 | Fireside Chat with Judge David Tatel

28 mins; July 19, 2024

VISIONS 2024 | An In-Depth Process of Applying for a Guide Dog

58 mins; July 19, 2024

VISIONS 2024 | Low Vision Aids and Devices

69 hours 53 mins; July 19, 2024

Click here to see more

Foundation Fighting Blindness

Useful pages

Find a tutor

Languages